#Pharmaceuticals

Articles (30)

• 🇺🇸 Form DEF 14A ANI PHARMACEUTICALS For: 9 April — 09/04/2026 [USA] Related: #Corporate Governance, #Regulatory Compliance
• 🇺🇸 ImmunityBio reports Q1 revenue of $44.2M, up 168% year-over-year — 09/04/2026 [USA] Related: #Biotechnology, #Corporate Earnings
• 🇺🇸 Lilly’s weight loss pill Foundayo now available in U.S. — 09/04/2026 [USA] Related: #Market Competition, #Healthcare Access
• 🇺🇸 Form DEF 14A Merck & Co. For: 8 April — 09/04/2026 [USA] Related: #Corporate Governance, #Financial Regulation
• 🇺🇸 The FDA approves a new obesity pill, giving patients another option — 01/04/2026 [USA]

  The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.

  Related: #Healthcare
• 🇺🇸 Leerink reiterates Rhythm Pharmaceuticals stock rating on CHMP opinion — 26/03/2026 [USA] Related: #Stock Market, #Regulatory Affairs
• 🇺🇸 Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss — 23/03/2026 [USA]

  Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

  Related: #Public Health
• 🇺🇸 Insmed reports positive Phase 3b trial results for MAC lung disease drug — 23/03/2026 [USA] Related: #Medical Trials
• 🇺🇸 GSK lung cancer drug receives orphan status in Japan — 23/03/2026 [USA] Related: #Regulatory Approval
• 🇺🇸 Form PRE 14A TONIX PHARMACEUTICALS HOLDING CORP. For: 20 March — 20/03/2026 [USA] Related: #Corporate Governance
• 🇺🇸 IGC Pharma earnings matched, revenue fell short of estimates — 20/03/2026 [USA] Related: #Earnings Report
• 🇺🇸 Tarsus Pharma general counsel Wahl sells $850k in stock — 19/03/2026 [USA] Related: #Insider Trading
• 🇺🇸 Tarsus Pharma COO Neervannan Seshadri sells $772k in shares — 19/03/2026 [USA] Related: #Insider Trading
• 🇺🇸 Farrow Jeffrey S of Tarsus Pharma sells $439k in shares — 19/03/2026 [USA] Related: #Insider Trading
• 🇺🇸 Truist reiterates Buy on Scholar Rock stock after Roche halts rival drug — 19/03/2026 [USA] Related: #Stock Analysis
• 🇺🇸 FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share — 19/03/2026 [USA]

  The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

  Related: #Weight Loss
• 🇺🇸 Barclays reiterates Collegium Pharmaceutical stock rating at Overweight — 19/03/2026 [USA] Related: #Stock Ratings
• 🇺🇸 Barclays reiterates Xeris Pharmaceuticals stock rating on sales outlook — 19/03/2026 [USA] Related: #Finance
• 🇺🇸 Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial — 19/03/2026 [USA]

  Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.

  Related: #Clinical Trials
• 🇺🇸 Guardian Pharmacy prices 6M share offering at $31 per share — 19/03/2026 [USA] Related: #Finance
• 🇺🇸 Ozempic Is About to Go Generic in India, China and Canada — 19/03/2026 [USA]

  In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

  Related: #Market Access
• 🇺🇸 Reviva Pharmaceuticals prices $10M public offering at $1.50 — 19/03/2026 [USA] Related: #Finance
• 🇺🇸 Truist initiates Altimmune stock coverage with buy rating on drug potential — 18/03/2026 [USA] Related: #Stock Analysis
• 🇺🇸 Truist initiates NewAmsterdam Pharma stock coverage with buy rating — 18/03/2026 [USA] Related: #Stock Coverage
• 🇺🇸 Barclays reiterates Overweight rating on ANI Pharmaceuticals stock — 18/03/2026 [USA] Related: #Stock Ratings
• 🇺🇸 FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi — 18/03/2026 [USA]

  Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.

  Related: #Healthcare
• 🇺🇸 Blau Farmacêutica 4Q25 slides: margin gains offset revenue miss — 18/03/2026 [USA] Related: #Earnings Report
• 🇺🇸 US FDA approves J&J’s oral psoriasis pill — 18/03/2026 [USA] Related: #Healthcare
• 🇺🇸 Medicus Pharma to host fireside chat on SkinJect trial results — 18/03/2026 [USA] Related: #Clinical Trials
• 🇬🇧 India's cheap weight-loss drugs could reshape global obesity fight — 18/03/2026 [United Kingdom]

  With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

  Related: #Healthcare